Infervision
Infervision is a medical artificial intelligence company that builds AI-powered medical imaging and clinical decision-support software for hospitals and healthcare providers. Its InferRead diagnostic suite assists radiologists with CT and DR reading across lung nodule detection, chest abnormality detection, coronary artery stenosis, stroke and hemorrhage triage, rib fracture identification, and pneumonia triage, while the InferOperate suite provides 3D reconstruction for thoracic, liver, and urological surgical planning. Additional platforms include InferCare for patient management and image follow-up, InferScholar for AI-enabled medical research, and the InferMatrix medical application platform. The company holds FDA 510(k) clearance for InferRead CT Lung, has filed 380+ patents and published 330+ peer-reviewed papers, and operates across 30+ countries. Infervision was surfaced through the API Evangelist network as a portfolio company of Qiming Venture Partners.
Infervision is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Medical Imaging, Healthcare, and Radiology.
Infervision’s developer surface includes support and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API